BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9291876)

  • 21. [Is registration of multiple myeloma in the Norwegian Cancer Registry good enough?].
    Aasbrenn M; Langmark F; Wisløff F
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2712-4. PubMed ID: 19079417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nephropathy in a patient with IgD-myeloma].
    Dimitrakov D; Karastanev I; Diukmedzhiev I; Goranov S
    Vutr Boles; 1979; 18(1):93-6. PubMed ID: 433257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunochemical Diagnosis of Multiple Myeloma.
    Lyubimova NV; Timofeev YS; Abaev VM; Votyakova OM; Kushlinskii NE
    Bull Exp Biol Med; 2018 May; 165(1):84-87. PubMed ID: 29797132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of paraproteinaemia.
    Cook L; Macdonald DH
    Postgrad Med J; 2007 Apr; 83(978):217-23. PubMed ID: 17403946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial immunopathies: report of nine families and survey of literature.
    Zawadzki ZA; Aizawa Y; Kraj MA; Haradin AR; Fisher B
    Cancer; 1977 Nov; 40(5):2094-101. PubMed ID: 336182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of multiple myeloma.
    Kyle RA
    Semin Oncol; 2002 Dec; 29(6 Suppl 17):2-4. PubMed ID: 12520477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry.
    Blimark CH; Turesson I; Genell A; Ahlberg L; Björkstrand B; Carlson K; Forsberg K; Juliusson G; Linder O; Mellqvist UH; Nahi H; Kristinsson SY;
    Haematologica; 2018 Mar; 103(3):506-513. PubMed ID: 29217784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [False diagnosis: rheumatism: osteochondrosis in plasmocytoma (paraproteinemia)].
    SCHMIDT KD
    Munch Med Wochenschr; 1956 Nov; 98(44):1501-2. PubMed ID: 13387553
    [No Abstract]   [Full Text] [Related]  

  • 29. The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance?
    Brigden ML
    Postgrad Med; 1999 Aug; 106(2):135-42; quiz 185. PubMed ID: 10456045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of leucocyte alkaline phosphatase (LAP) score in differentiating malignant from benign paraproteinaemias.
    Majumdar G; Hunt M; Singh AK
    J Clin Pathol; 1991 Jul; 44(7):606-7. PubMed ID: 1713223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of the bone marrow plasma cell cytoplasmic light chain ratio in differentiating between multiple myeloma and monoclonal gammopathy of undetermined significance.
    Majumdar G; Grace RJ; Singh AK; Slater NG
    Leuk Lymphoma; 1992 Dec; 8(6):491-3. PubMed ID: 1297481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lambda light chain myeloma with co-migrating paraprotein at beta region on agarose gel electrophoresis: a case report.
    Siti Sarah M; Nor Aini U; Nurismah MI; Hafiza A; Khalidah M; Mokhtar AB; Das S
    Clin Ter; 2014; 165(1):35-9. PubMed ID: 24589949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraproteinemia, plasmacytoma, myeloma and HIV infection.
    Fiorino AS; Atac B
    Leukemia; 1997 Dec; 11(12):2150-6. PubMed ID: 9447834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study.
    Brink M; Groen K; Sonneveld P; Minnema MC; Broijl A; Dinmohamed AG; van der Spek E; Levin MD; Ypma PF; de Waal E; Posthuma EFMW; Zweegman S; van de Donk NWCJ
    Blood Cancer J; 2021 Nov; 11(11):178. PubMed ID: 34764237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic criteria of multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum siliac acid in patients with multiple myeloma.
    Richards SJ; Rawstron AC
    Br J Biomed Sci; 1997 Mar; 54(1):72. PubMed ID: 9167310
    [No Abstract]   [Full Text] [Related]  

  • 38. [Monoclonal gammopathies--from MGUS to myeloma].
    Hess U; Heijnen IA
    Ther Umsch; 2004 Feb; 61(2):161-7. PubMed ID: 15018400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotactoid keratopathy: a clinicopathologic case report and a review of reports of corneal involvement in systemic paraproteinemias.
    Garibaldi DC; Gottsch J; de la Cruz Z; Haas M; Green WR
    Surv Ophthalmol; 2005; 50(1):61-80. PubMed ID: 15621078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Importance of selected laboratory indicators in the differential diagnosis and monitoring of multiple myeloma].
    Maisnar V; Tousková M; Malý J; Krejsek J; Kmonícek M; Kopecký O
    Vnitr Lek; 2002 Apr; 48(4):290-7. PubMed ID: 12061177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.